BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24609624)

  • 21. Sustained increased intraocular pressure related to intravitreal antivascular endothelial growth factor therapy for neovascular age-related macular degeneration.
    Tseng JJ; Vance SK; Della Torre KE; Mendonca LS; Cooney MJ; Klancnik JM; Sorenson JA; Freund KB
    J Glaucoma; 2012; 21(4):241-7. PubMed ID: 21423038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial.
    Heier JS; Campochiaro PA; Yau L; Li Z; Saroj N; Rubio RG; Lai P
    Ophthalmology; 2012 Apr; 119(4):802-9. PubMed ID: 22301066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optic atrophy after anti-vascular endothelial growth factor injection in diabetic patients with proliferative diabetic retinopathy.
    Singalavanija A; Hemarat K; Kedkovid N; Tanterdtham J; Namatra C; Trinavarat A; Rodanant N; Thoongsuwan S
    J Med Assoc Thai; 2013 Mar; 96(3):318-23. PubMed ID: 23539935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect on intraocular pressure in patients receiving unilateral intravitreal anti-vascular endothelial growth factor injections.
    Hoang QV; Mendonca LS; Della Torre KE; Jung JJ; Tsuang AJ; Freund KB
    Ophthalmology; 2012 Feb; 119(2):321-6. PubMed ID: 22054994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rates of RNFL Thinning in Patients with Suspected or Confirmed Glaucoma Receiving Unilateral Intravitreal Injections for Exudative AMD.
    Swaminathan SS; Kunkler AL; Quan AV; Medert CM; Vanner EA; Feuer W; Chang TC
    Am J Ophthalmol; 2021 Jun; 226():206-216. PubMed ID: 33359714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Super-dose anti-VEGF (SAVE) trial: 2.0 mg intravitreal ranibizumab for recalcitrant neovascular macular degeneration-primary end point.
    Brown DM; Chen E; Mariani A; Major JC;
    Ophthalmology; 2013 Feb; 120(2):349-54. PubMed ID: 23131717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in the Ganglion Cell-inner Plexiform Layer after Consecutive Intravitreal Injections of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration Patients.
    Kim SY; Yoon MH; Chin HS
    Korean J Ophthalmol; 2020 Feb; 34(1):11-18. PubMed ID: 32037745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Intravitreal Anti-VEGF Therapy on Glaucoma-like Progression in Susceptible Eyes.
    Du J; Patrie JT; Prum BE; Netland PA; Shildkrot YE
    J Glaucoma; 2019 Dec; 28(12):1035-1040. PubMed ID: 31633617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of age-related macular degeneration on macular thickness measurement made with fourier-domain optical coherence tomography.
    Garas A; Papp A; Holló G
    J Glaucoma; 2013 Mar; 22(3):195-200. PubMed ID: 22314250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for exudative age-related macular degeneration.
    Lee SJ; Koh HJ
    Ophthalmology; 2011 Jan; 118(1):101-10. PubMed ID: 20678805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis.
    Fisher JB; Jacobs DA; Markowitz CE; Galetta SL; Volpe NJ; Nano-Schiavi ML; Baier ML; Frohman EM; Winslow H; Frohman TC; Calabresi PA; Maguire MG; Cutter GR; Balcer LJ
    Ophthalmology; 2006 Feb; 113(2):324-32. PubMed ID: 16406539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of Dexamethasone Intravitreal Implant on Retinal Nerve Fiber Layer in Patients Diagnosed with Branch Retinal Vein Occlusion.
    Ayar O; Alpay A; Koban Y; Akdemir MO; Yazgan S; Canturk Ugurbas S; Ugurbas SH
    Curr Eye Res; 2017 Sep; 42(9):1287-1292. PubMed ID: 28632411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of sustained intraocular pressure elevation in eyes receiving intravitreal anti-vascular endothelial growth factor therapy.
    Yannuzzi NA; Patel SN; Bhavsar KV; Sugiguchi F; Freund KB
    Am J Ophthalmol; 2014 Aug; 158(2):319-327.e2. PubMed ID: 24814167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of retinal sensitivity and morphology during antiangiogenic treatment of retinal vein occlusion over one year.
    Kriechbaum K; Prager F; Geitzenauer W; Benesch T; Schütze C; Simader C; Schmidt-Erfurth U
    Ophthalmology; 2009 Dec; 116(12):2415-21. PubMed ID: 19744723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinal nerve fiber layer thickness in a population of 12-year-old children in central China measured by iVue-100 spectral-domain optical coherence tomography: the Anyang Childhood Eye Study.
    Zhu BD; Li SM; Li H; Liu LR; Wang Y; Yang Z; Li SY; Kang MT; Fu J; Qi YH; Zhan SY; Wang N;
    Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8104-11. PubMed ID: 24150754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
    Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
    Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scleral thinning after repeated intravitreal injections of antivascular endothelial growth factor agents in the same quadrant.
    Zinkernagel MS; Schorno P; Ebneter A; Wolf S
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1894-900. PubMed ID: 25711641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.